FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074399282> ?p ?o ?g. }

• W2074399282 endingPage "226" @default.
• W2074399282 startingPage "222" @default.
• W2074399282 abstract "Annals of the New York Academy of SciencesVolume 565, Issue 1 p. 222-226 Chemotherapy and Hemoglobin F Synthesis in Sickle Cell Diseasea GEORGE J. DOVER, GEORGE J. DOVER Departments of Pediatrics and Medicine Johns Hopkins University Medical School 720 Rutland Avenue 906 Traylor Building Baltimore, Maryland 21205Search for more papers by this authorSAMUEL CHARACHE, SAMUEL CHARACHE Departments of Pathology and Laboratory Medicine The Johns Hopkins Hospital 600 North Wolf Street B121D Meyer Building Baltimore, Maryland 21205Search for more papers by this author GEORGE J. DOVER, GEORGE J. DOVER Departments of Pediatrics and Medicine Johns Hopkins University Medical School 720 Rutland Avenue 906 Traylor Building Baltimore, Maryland 21205Search for more papers by this authorSAMUEL CHARACHE, SAMUEL CHARACHE Departments of Pathology and Laboratory Medicine The Johns Hopkins Hospital 600 North Wolf Street B121D Meyer Building Baltimore, Maryland 21205Search for more papers by this author First published: July 1989 https://doi.org/10.1111/j.1749-6632.1989.tb24170.xCitations: 5 a Supported by National Institutes of Health grants no. HJL-02799 and NHLB R01 28028-07, General Clinical Research Center grant no. RR35, Outpatient Research Center grant no. RR 00722, and a grant from the Central Maryland Committee on Sickle Cell Anemia, Inc. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Watson, J. 1948. The significance of the paucity of sickle cells in newborn Negro infants. Am. J. Med. Sci. 215: 419. 2 Herman, E. C., Jr & C. L. Conley. 1960. Hereditary persistence of fetal hemoglobin. A family study. Am. J. Med. 29: 9. 3 Singer, K. & L. Singer. 1953. Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle-cell hemoglobin: its biologic and diagnostic significance. Blood 8: 1008. 4 Bertles, J. F., R. Rabinowitz & J. Dobler. 1970. Hemoglobin interaction: modification of solid phase composition in the sickling phenomenon. Science 169: 375. 5 Nagel, R. L., R. M. Bookchin, J. Johnson, D. Labie, H. Wajcman, W. A. Isaac-Sodeye, G. R. Honig, G. Schiliro, J. H. Crookston & K. Matsumoto. 1979. Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. Proc. Nat. Acad. Sci. USA 76: 670. 6 Goldberg, M. A., M. A. Husson & H. F. Bunn. 1977. Participation of hemoglobins A and F in polymerization of sickle hemoglobin. J. Biol. Chem. 252: 3414. 7 Stamatoyannopoulos, G. & A. Nienhuis. 1983. Globin Gene Expression and Hemopoietic Differentiation. Alan R. Liss, Inc. New York , N.Y. 8 De Simone, J., P. Heller, L. Hall & D. Zwiers. 1982. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc. Nat. Acad. Sci. USA 79: 4428. 9 Ley, T. J., J. De Simone, N. P. Anagnou, G. H. Keller, R. K. Humphries, P. H. Turner, N. S. Young, P. Heller & A. W. Nienhuis. 1982. 5-Azacytidine selectively increases gamma-globulin synthesis in a patient with beta-plus thalassemia. N. Engl. J. Med. 307: 1469. 10 Ley, T. J., J. De Simone, C. T. Noguchi, P. H. Turner, A. N. Schechter, P. Heller & A. W. Nienhuis. 1983. 5-Azacytidine increases γ-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood 62(2): 370– 380. 11 Charache, S., G. J. Dover, K. D. Smith & C. C. Talbot. 1983. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with non-random hypo-methylation of DNA around the γ-δ-B globin gene complex. Proc. Nat. Acad. Sci. USA 80: 4842. 12 Dover, G. J., S. Charache, S. H. Boyer, G. Vogelsang & M. Mover. 1985. 5-Azacytidine increases Hb F production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens. Blood 66: 527. 13 Letvin, N. L., D. C. Linch, P. Beardsley, K. W. McIntyre & D. G. Nathan. 1984. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N. Engl. J. Med. 310: 869. 14 Papayannopoulou, T., A. Torjealba-Deron, R. Veith, G. Knitter & E. Stamatoyannopoulou. 1984. Arabinosylcytosine induces fetal hemoglobins in baboons by perturbing erythroid cell differentiation kinetics. Science 224: 617– 619. 15 Letvin, N. L., D. L. Linch, T. P. Beardsley, K. W. McIntyre, B. Miller & D. G. Nathan. 1985. Influence of cell cycle specific agents on simian fetal hemoglobin synthesis. J. Clin. Invest. 75: 1999. 16 Platt, O. S., S. H. Orkin, G. Dover, G. P. Beardsley, B. Miller & D. G. Nathan. 1984. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J. Clin. Invest. 74: 652. 17 Veith, R., R. Galanello, T. Papayannopoulou & G. Stamatoyannopoulos. 1985. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytara-bine or hydroxyurea. N. Engl. J. Med. 313: 1571. 18 Kaplan, M. E., K. Mack, J. D. Goldberg, P. B. Donovan, P. D. Berk & L. R. Wasserman. 1986. Long term management of polycythemia vera with hydroxyurea: a progress report. Semin. Hematol. 23: 167. 19 Dover, G. J., R. K. Humphries, J. G. Moore, T. J. Ley, N. S. Young, S. Charache & A. W. Nienhuis. 1986. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. Blood 67: 735. 20 Charache, S., G. J. Dover, M. A. Mover & J. W. Moore. 1987. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood 69: 109– 116. 21 Sumoza, A. & R. S. Biscotti. 1986. Treatment of sickle cell anemia with hydroxyurea. Blood 68: 67a. 22 Alter, B. P. & H. S. Gilbert. 1985. The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromes. Blood 66: 373. 23 Veith, R., T. Papayannopoulou, S. Kurachi & G. Stamatoyannopoulou. 1985. Treatment of baboon with vinblastine: insights into the mechanism of pharmacologic stimulation of HbF in the adult. Blood 66: 456– 459. 24 Perrine, S., Y. W. Kan, M. F. Greene, E. Rubin, S. Cooper, R. Cohen, C. Roman, A. Rudolph & D. V. Faller. 1987. Inhibition of fetal globin gene switching in vivo in human and ovine fetuses. Prog. Clin. Biol. Res. 251: 545– 554. 25 Al-Khatti, A., R. W. Veith, T. Papayannopoulou, E. F. Fritsch, E. Goldwasser & E. Stamatoyannopoulou. 1987. Stimulation of fetal hemoglobin synthesis by erythro-poietin in baboons. N. Engl. J. Med. 317: 415– 420. 26 Torrealba-de Ron, A. T., T. Papayannopoulou, M. S. Knapp, M. F. Fu, G. Knitter & G. Stamatoyannopoulos. 1984. Perturbations in erythroid marrow progenitor cell pool may play a role in augmentation of HbF by 5-azacytidine. Blood 63: 201. 27 Humphries, R. K., G. Dover, N. S. Young, J. G. Moore, S. Charache, T. Ley & A. W. Nienhuis. 1985. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin. J. Clin. Invest. 75: 547. Citing Literature Volume565, Issue1Sickle Cell DiseaseJuly 1989Pages 222-226 ReferencesRelatedInformation" @default.
• W2074399282 created "2016-06-24" @default.
• W2074399282 creator A5009862383 @default.
• W2074399282 creator A5018004404 @default.
• W2074399282 date "1989-07-01" @default.
• W2074399282 modified "2023-10-17" @default.
• W2074399282 title "Chemotherapy and Hemoglobin F Synthesis in Sickle Cell Disease" @default.
• W2074399282 cites W1515900859 @default.
• W2074399282 cites W1522200025 @default.
• W2074399282 cites W1977508606 @default.
• W2074399282 cites W1987037884 @default.
• W2074399282 cites W1992578822 @default.
• W2074399282 cites W1996043889 @default.
• W2074399282 cites W2000881989 @default.
• W2074399282 cites W2022529274 @default.
• W2074399282 cites W2043634525 @default.
• W2074399282 cites W2048441226 @default.
• W2074399282 cites W2049129790 @default.
• W2074399282 cites W2053084472 @default.
• W2074399282 cites W2130418657 @default.
• W2074399282 cites W2285115828 @default.
• W2074399282 cites W230020387 @default.
• W2074399282 cites W2318281771 @default.
• W2074399282 cites W2322276889 @default.
• W2074399282 cites W2339887069 @default.
• W2074399282 cites W2975770818 @default.
• W2074399282 cites W4233402941 @default.
• W2074399282 cites W4250085880 @default.
• W2074399282 cites W82508867 @default.
• W2074399282 cites W91104177 @default.
• W2074399282 doi "https://doi.org/10.1111/j.1749-6632.1989.tb24170.x" @default.
• W2074399282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2476061" @default.
• W2074399282 hasPublicationYear "1989" @default.
• W2074399282 type Work @default.
• W2074399282 sameAs 2074399282 @default.
• W2074399282 citedByCount "8" @default.
• W2074399282 countsByYear W20743992822013 @default.
• W2074399282 countsByYear W20743992822015 @default.
• W2074399282 crossrefType "journal-article" @default.
• W2074399282 hasAuthorship W2074399282A5009862383 @default.
• W2074399282 hasAuthorship W2074399282A5018004404 @default.
• W2074399282 hasConcept C126322002 @default.
• W2074399282 hasConcept C1491633281 @default.
• W2074399282 hasConcept C2776694085 @default.
• W2074399282 hasConcept C2778620579 @default.
• W2074399282 hasConcept C2778917026 @default.
• W2074399282 hasConcept C2779134260 @default.
• W2074399282 hasConcept C3020314195 @default.
• W2074399282 hasConcept C54355233 @default.
• W2074399282 hasConcept C71924100 @default.
• W2074399282 hasConcept C86803240 @default.
• W2074399282 hasConceptScore W2074399282C126322002 @default.
• W2074399282 hasConceptScore W2074399282C1491633281 @default.
• W2074399282 hasConceptScore W2074399282C2776694085 @default.
• W2074399282 hasConceptScore W2074399282C2778620579 @default.
• W2074399282 hasConceptScore W2074399282C2778917026 @default.
• W2074399282 hasConceptScore W2074399282C2779134260 @default.
• W2074399282 hasConceptScore W2074399282C3020314195 @default.
• W2074399282 hasConceptScore W2074399282C54355233 @default.
• W2074399282 hasConceptScore W2074399282C71924100 @default.
• W2074399282 hasConceptScore W2074399282C86803240 @default.
• W2074399282 hasIssue "1 Sickle Cell D" @default.
• W2074399282 hasLocation W20743992821 @default.
• W2074399282 hasLocation W20743992822 @default.
• W2074399282 hasOpenAccess W2074399282 @default.
• W2074399282 hasPrimaryLocation W20743992821 @default.
• W2074399282 hasRelatedWork W1677407482 @default.
• W2074399282 hasRelatedWork W184984064 @default.
• W2074399282 hasRelatedWork W2057631009 @default.
• W2074399282 hasRelatedWork W2184780905 @default.
• W2074399282 hasRelatedWork W2371666691 @default.
• W2074399282 hasRelatedWork W2378355431 @default.
• W2074399282 hasRelatedWork W2577923170 @default.
• W2074399282 hasRelatedWork W2593380934 @default.
• W2074399282 hasRelatedWork W3040509277 @default.
• W2074399282 hasRelatedWork W297218639 @default.
• W2074399282 hasVolume "565" @default.
• W2074399282 isParatext "false" @default.
• W2074399282 isRetracted "false" @default.
• W2074399282 magId "2074399282" @default.
• W2074399282 workType "article" @default.